Indivior | DEBITO



Debt Cambiamento Data
AstraZeneca USD 30.3B 1.27B 2024-12
Eli Lilly USD 33.64B 2.52B 2024-12
Glaxosmithkline GBP 16.99B 927M 2024-12
Halozyme Therapeutics USD 1.51B 1.64M 2024-12
Indivior 329M 4M 2025-03
J&J USD 36.63B 883M 2024-12
Kyowa Hakko Kirin JPY 28.75B 5.04B 2024-12
Merck USD 37.11B 1.02B 2024-12
Novartis USD 31.26B 828M 2024-12
Pfizer USD 64.35B 3.35B 2024-12
Sanofi 17.91B 5.85B 2024-12
Supernus Pharmaceuticals USD 0 0 2024-12



Indivior DEBITO - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.